Mobile menu

French Parasitology Alliance For Health Care


 

  Didier Menard

Didier MENARD

Information

microscope Malaria Genetics and Resistance Unit 
team Malaria Genetics and Resistance Unit 
location Paris
orcid 0000-0003-1357-4495 
email This email address is being protected from spambots. You need JavaScript enabled to view it.
website https://research.pasteur.fr/en/member/didier-menard/

Scientific interests and projects

After almost twenty years (2000-2017) spent in the Institut Pasteur International Network (IPIN), in Africa (Central African Republic, Madagascar) and in Southeast Asia (Cambodia), I decided to move back to Paris. Since September 2017, I lead a new group named ‘Malaria Genetics and Resistance’ into the Biology of Interactions Host-Parasite unit headed by Artur Scherf at Institut Pasteur, Paris. In 2020, I will head an unit (U5).

Along my different positions in the IPIN, my research program was focused at studying and deciphering Plasmodium falciparum resistance to antimalarial drugs. My major achievements were to elucidate and define the molecular signatures associated to artemisinin resistance (mutations in the propeller domain of a Kelch gene located on chromosome 13, K13) and to piperaquine resistance (amplification of a cluster of genes encoding emoglobin digesting proteases, Plasmepsin 2-3). Following these major breakthroughs, I led in 2015-2016, a worldwide consortium (KARMA project, 41 partners located in 59 endemic countries) which aimed at providing the first global mapping of artemisinin resistance. I was also involved in the first report describing the emergence of indigenous artemisinin resistance in Africa. In parallel, I conducted comparative genomic studies of P. vivax field isolates. First, we observed the frequent duplication of the gene encoding Duffy Binding Protein (PvDBP) in Malagasy P. vivax strains and second, we identified a novel gene encoding a homolog of PvDBP referred to as P. vivax erythrocyte binding protein (PvEBP).

The scientific programme of the ‘Malaria Genetics and Resistance’ Unit will aim at developing new translational projects focused on the scientific questions emerging from the field and covering two main topics: Studying P. falciparum antimalarial drugs resistance & Deciphering P. vivax invasion pathways into human reticulocytes.

I have published 183 peer-review articles in international journals. In 2015, I received the Eloi Collery prize from the National Academy of Medicine (France) and in 2016 the Jean Pierre Lecocq prize from the Sciences Academy (France).

Top 5 publications of last 5 years

Khim N, Zhang L, Lam S, Gregory PD, Urnov FD, Mercereau-Puijalon O, Benoit-Vical F, Fairhurst RM, Ménard D, Fidock DA. Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science. 2015 Jan 23;347(6220):428-31. doi: 10.1126/science.1260867

2. Ménard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, Rahim-Awab G, Barnadas C, Berry A, Boum Y, Bustos MD, Cao J, Chen JH, Collet L, Cui L, Thakur GD, Dieye A, Djallé D, Dorkenoo MA, Eboumbou-Moukoko CE, Espino FE, Fandeur T, Ferreirada- Cruz MF, Fola AA, Fuehrer HP, Hassan AM, Herrera S, Hongvanthong B, Houzé S, Ibrahim ML, Jahirul-Karim M, Jiang L, Kano S, Ali-Khan W, Khanthavong M, Kremsner PG, Lacerda M, Leang R, Leelawong M, Li M, Lin K, Mazarati JB, Ménard S, Morlais I, Muhindo- Mavoko H, Musset L, Na-Bangchang K, Nambozi M, Niaré K, Noedl H, Ouédraogo JB, Pillai DR, Pradines B, Quang-Phuc B, Ramharter M, Randrianarivelojosia M, Sattabongkot J, Sheikh-Omar A, Silué KD, Sirima SB, Sutherland C, Syafruddin D, Tahar R, Tang LH, Touré OA, Tshibangu-wa-Tshibangu P, Vigan-Womas I, Warsame M, Wini L, Zakeri S, Kim S, Eam R, Berne L, Khean C, Chy S, Ken M, Loch K, Canier L, Duru V, Legrand E, Barale JC, Stokes B, Straimer J, Witkowski B, Fidock DA, Rogier C, Ringwald P, Ariey F, Mercereau-Puijalon O; KARMA Consortium. A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms. N Engl J Med. 2016 Jun 23;374(25):2453-64. doi: 10.1056/NEJMoa1513137.

3. Witkowski B, Duru V, Khim N, Ross LS, Saintpierre B, Beghain J, Chy S, Kim S, Ke S, Kloeung N, Eam R, Khean C, Ken M, Loch K, Bouillon A, Domergue A, Ma L, Bouchier C, Leang R, Huy R, Nuel G, Barale JC, Legrand E, Ringwald P, Fidock DA, Mercereau-Puijalon O, Ariey F, Ménard D. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study. Lancet Infect Dis. 2017 Feb;17(2):174- 183. doi: 10.1016/S1473-3099(16)30415-7.

4. Menard D, Dondorp A. Antimalarial Drug Resistance: A Threat to Malaria Elimination. Cold Spring Harb Perspect Med. 2017 Jul 5;7(7). pii: a025619. doi: 10.1101/cshperspect.a025619. Review.

5. Kim A, Popovici J, Menard D, Serre D. Plasmodium vivax transcriptomes reveal stagespecific chloroquine response and differential regulation of male and female gametocytes. Nat Commun. 2019 Jan 22;10(1):371. doi: 10.1038/s41467-019-08312-z